The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners.
The objective is to integrate the about 120 leading leukemia trial groups (CML, AML, ALL, CLL, MDS, MPN), their interdisciplinary partner groups (diagnostics, ...
Missing: national | Show results with:national
The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners ( ...
People also ask
What is the European LeukemiaNet?
How does MDS differ from AML?
The only way to cure leukemia is by cooperative research. To optimize research, the European LeukemiaNet integrates 105 national leukemia trial groups and ...
Missing: leading | Show results with:leading
The main objective of this project is to integrate the leading European national trial groups in CML to form a cooperative network for advancements in CML ...
Dec 8, 2009 · However, an EU-funded team of researchers is raising the bar by integrating the work of leading trial groups, their partner groups, industry and ...
Main focus of the European LeukemiaNet is to ... integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe
The ELN Foundation is a foundation of private law. Its goal is to support the European LeukemiaNet (ELN), a publicly funded research network of excellence.
The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners ...
The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners ...
